DUN & BRADSTREET LIMITED

1. Financial Health Score: B+

Explanation: Dun & Bradstreet Limited presents as a robust, long-standing corporate entity with excellent structural health and regulatory compliance. The grade of B+ reflects a strong constitution—bolstered by over a century of operational history and substantial share capital—rather than acute financial distress. However, because the detailed "blood work" (specific profit and loss figures, liquidity ratios, and cash flow statements) is limited by the data provided, a perfect grade cannot be issued without confirming the absence of underlying metabolic issues such as hidden liabilities or thin margins.

2. Key Vital Signs

• Pulse (Operational Status & Age): Strong and steady. Incorporated in 1919, the company has a corporate heartbeat spanning over a century. Surviving multiple economic cycles indicates a highly resilient business model and strong institutional immunity.
• Blood Pressure (Filing Compliance): Optimal. The company’s accounts are made up to December 31, 2024, with the next due date in September 2026, and the confirmation statement is current. There are no overdue filings. This shows excellent administrative health and a low-stress regulatory posture.
• Bone Density (Capitalization): Very High. With a share capital of just over £20.6 million, the company possesses a dense, sturdy structural foundation. This is not a thin-capitalized shell; it has substantial equity committed to the business.
• DNA (Corporate Lineage & Control): Integrated. The company is majority-owned (over 75% of shares) by D&B Europe Limited. It operates as a vital organ within a larger, global corporate body (the Dun & Bradstreet network).

3. Diagnosis

Symptoms Analysis: Currently, there are absolutely no symptoms of financial distress. The company is active, not in liquidation, administration, or receivership. There are no red flags such as overdue filings or director disqualifications among the current officers. The presence of a "Worldwide Network Leader" among the board of directors (Sabine Leferink) indicates that the UK entity is closely tied to the strategic nervous system of the global parent company.

Diagnosis: The patient is a healthy, functioning subsidiary of a multinational enterprise. The primary condition to note is its status as a dependent entity—its financial wellness is intrinsically linked to the systemic health of its parent, D&B Europe Limited. Because the company files full rather than micro or small accounts, it possesses a complex financial anatomy, but the substantial share capital suggests it is well-capitalized against its operational risks.

Prognosis: The future outlook is highly positive, assuming the parent company remains healthy. As a crucial part of the Dun & Bradstreet global infrastructure, the UK arm benefits from a strong "immune system"—meaning it has access to group resources, shared services, and brand equity that protect it from localized market infections. Barring a systemic failure at the global parent level, this company is expected to continue operating as a stable, going concern.

4. Recommendations

To maintain and improve financial wellness, the following preventative care measures are recommended:

1. Monitor Intercompany Vital Signs: Because the company is heavily owned by D&B Europe Limited, it is vital to monitor the health of intercompany balances. Ensure that loans or transactions between the parent and subsidiary are conducted at arm's length and do not result in cash flow anemia for the UK entity.
2. Routine Blood Work (Financial Review): While compliance filings are current and healthy, stakeholders should regularly review the full filed accounts at Companies House to check the "cholesterol" levels—specifically, monitoring whether current liabilities are outpacing current assets, which could indicate working capital stress.
3. Director Succession Planning: With a robust board of six directors and a secretary, ensure that there is ongoing succession planning to prevent any leadership vacuum, keeping the corporate governance healthy and responsive.